atenolol has been researched along with Secondary Hyperparathyroidism in 2 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Makdassi, R | 2 |
Andrejak, M | 2 |
Morinière, P | 2 |
Sebert, JL | 1 |
Decourt, S | 1 |
Guéris, J | 1 |
Coevoet, B | 2 |
Fournier, A | 2 |
Decourcelle, PH | 1 |
de Fremont, JF | 1 |
Kassouf, J | 1 |
Roussel, A | 1 |
Gheerbrand, JD | 1 |
2 other studies available for atenolol and Secondary Hyperparathyroidism
Article | Year |
---|---|
Comparison of propranolol and atenolol in the control of hyperparathyroidism in uremia.
Topics: Adult; Aged; Atenolol; Bicarbonates; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Ag | 1982 |
Blockers of beta and H2 receptors and secondary hyperparathyroidism in uraemia.
Topics: Adult; Aged; Atenolol; Cimetidine; Female; Guanidines; Humans; Hyperparathyroidism, Secondary; Male; | 1981 |